vs

Side-by-side financial comparison of ORRSTOWN FINANCIAL SERVICES INC (ORRF) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $64.6M, roughly 1.3× ORRSTOWN FINANCIAL SERVICES INC). ORRSTOWN FINANCIAL SERVICES INC runs the higher net margin — 33.8% vs -38.1%, a 71.8% gap on every dollar of revenue. Over the past eight quarters, ORRSTOWN FINANCIAL SERVICES INC's revenue compounded faster (39.3% CAGR vs 24.8%).

Orrstown Financial Services Inc is a US regional bank holding company headquartered in Shippensburg, Pennsylvania. It offers a full range of retail and commercial banking solutions including deposit accounts, personal and business loans, mortgages, and wealth management services, primarily serving customers across central Pennsylvania and northern Maryland.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ORRF vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$64.6M
ORRF
Higher net margin
ORRF
ORRF
71.8% more per $
ORRF
33.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
ORRF
ORRF
Annualised
ORRF
39.3%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ORRF
ORRF
PRCT
PRCT
Revenue
$64.6M
$83.1M
Net Profit
$21.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
33.8%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
19.1%
-27.9%
EPS (diluted)
$1.12
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORRF
ORRF
PRCT
PRCT
Q1 26
$64.6M
$83.1M
Q4 25
$64.9M
$76.4M
Q3 25
$64.4M
$83.3M
Q2 25
$62.4M
$79.2M
Q1 25
$60.4M
$69.2M
Q4 24
$61.8M
$68.2M
Q3 24
$64.1M
$58.4M
Q2 24
$33.3M
$53.4M
Net Profit
ORRF
ORRF
PRCT
PRCT
Q1 26
$21.8M
$-31.6M
Q4 25
$21.5M
$-29.8M
Q3 25
$21.9M
$-21.4M
Q2 25
$19.4M
$-19.6M
Q1 25
$18.1M
$-24.7M
Q4 24
$13.7M
$-18.9M
Q3 24
$-7.9M
$-21.0M
Q2 24
$7.7M
$-25.6M
Gross Margin
ORRF
ORRF
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ORRF
ORRF
PRCT
PRCT
Q1 26
-4.1%
Q4 25
42.3%
-40.6%
Q3 25
43.0%
-27.8%
Q2 25
39.6%
-28.0%
Q1 25
37.7%
-39.7%
Q4 24
27.7%
-28.9%
Q3 24
-15.4%
-38.4%
Q2 24
29.5%
-50.3%
Net Margin
ORRF
ORRF
PRCT
PRCT
Q1 26
33.8%
-38.1%
Q4 25
33.1%
-39.1%
Q3 25
34.0%
-25.7%
Q2 25
31.2%
-24.7%
Q1 25
29.9%
-35.8%
Q4 24
22.1%
-27.6%
Q3 24
-12.3%
-35.9%
Q2 24
23.3%
-48.0%
EPS (diluted)
ORRF
ORRF
PRCT
PRCT
Q1 26
$1.12
$-0.56
Q4 25
$1.11
$-0.54
Q3 25
$1.13
$-0.38
Q2 25
$1.01
$-0.35
Q1 25
$0.93
$-0.45
Q4 24
$0.35
$-0.34
Q3 24
$-0.41
$-0.40
Q2 24
$0.73
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORRF
ORRF
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$161.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$603.2M
$347.7M
Total Assets
$5.6B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORRF
ORRF
PRCT
PRCT
Q1 26
$161.8M
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
ORRF
ORRF
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
ORRF
ORRF
PRCT
PRCT
Q1 26
$603.2M
$347.7M
Q4 25
$591.5M
$365.9M
Q3 25
$571.9M
$380.3M
Q2 25
$548.4M
$385.8M
Q1 25
$532.9M
$389.2M
Q4 24
$516.7M
$402.2M
Q3 24
$516.2M
$241.2M
Q2 24
$278.4M
$251.8M
Total Assets
ORRF
ORRF
PRCT
PRCT
Q1 26
$5.6B
$487.1M
Q4 25
$5.5B
$508.1M
Q3 25
$5.5B
$511.5M
Q2 25
$5.4B
$513.1M
Q1 25
$5.4B
$519.4M
Q4 24
$5.4B
$534.0M
Q3 24
$5.5B
$374.1M
Q2 24
$3.2B
$374.4M
Debt / Equity
ORRF
ORRF
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORRF
ORRF

Net Interest Income$49.0M76%
Noninterest Income$15.6M24%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons